The North America automated cell cultures market is witnessing significant growth due to the rising adoption of automated systems in cell biology, drug discovery, and protein expression research. These systems offer time-saving and error-reducing benefits, appealing to labs working with cell cultures. The market is also driven by the increasing demand for 3D cell cultures, growing collaborations among market players, and the rise of outsourcing facilities.
According to Data Bridge Market Research, the North America Automated Cell Cultures Market is growing with a CAGR of 9.1% in the forecast period of 2022 to 2029 and is expected to reach EURO 7,797.02 million by 2029.
“The increasing demand for cell culture technology in vaccine production facilitates market growth”
The increasing demand for cell culture technology in vaccine production is a major driver of the North America automated cell cultures market. Cell culture technology plays a crucial role in the development and production of vaccines. Automated cell culture systems offer advantages such as high throughput, reproducibility, and efficiency, making them essential in vaccine manufacturing processes. With the rising need for vaccines, particularly during pandemics and infectious disease outbreaks, the adoption of automated cell culture systems is expected to surge, driving market growth in North America.
What restraints the growth of North America automated cell cultures market?
“The high cost of automated cell culture systems”
The high cost of automated cell culture systems serves as a significant restraint on the North America automated cell cultures market. The initial investment required to implement these sophisticated systems can be substantial, especially for small and medium-sized research or biotech companies. Additionally, maintenance and operational expenses for automated cell culture systems can also be significant. The high cost of adoption may deter some potential buyers, limiting the market's growth and adoption rate, despite the advantages offered by automated systems in cell culture research and bioprocessing.
Segmentation: North America Automated Cell Cultures Market
The North America automated cell cultures market is segmented on the basis of product type, usage, and route of administration, application, end user, and distribution channel.
- On the basis of product, the North America automated cell cultures market is segmented into consumables, and instruments.
- On the basis of type, the North America automated cell cultures market is segmented into infinite cell line cultures, and finite cell line cultures.
- On the basis of application, the North America automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccines, and others.
- On the basis of end user, the North America automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes, and other.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/north-america-automated-cell-cultures-market
Recent Developments in North America Automated Cell Cultures Market
- In August 2021, Advanced Instruments signed a definitive agreement to acquire Solentim, a leader in solutions for isolating and characterizing high-value single-cell clones in cell line development applications. The acquisition strengthens both companies' positions in bioprocess workflows for advanced therapies, enhancing their capabilities in the bioprocessing industry.
- In July 2021, BD launched bdbiosciences.com, an updated digital marketplace for flow cytometry. The new website provides flow cytometry users and procurement teams with an improved online purchasing experience, offering a range of advanced features and functionalities for efficient flow cytometry product procurement.
The Prominent Key Players Operating in the North America Automated Cell Cultures Market Include:
- Lonza (Switzerland)
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- BD (Becton, Dickinson and Company) (U.S.)
- Eppendorf AG (Germany)
- Advanced Instruments (U.S.)
- Benchmark Scientific, Inc. (U.S.)
- BioSpherix, Ltd. (U.S.)
- Biotron Healthcare (India)
- Bulldog Bio (U.S.)
- Cell Culture Company, LLC (U.S.)
- CellGenix GmbH (Germany)
- ChemoMetec (Denmark)
- Corning Incorporated (U.S.)
- Cytiva (Subsidiary of Danaher Corporation) (U.S.)
- FUJIFILM Holdings America Corporation (U.S.)
- Hamilton Company (U.S.)
- Hitachi, Ltd. (Japan)
- Kawasaki Heavy Industries, Ltd. (Japan)
- HiMedia Laboratories (India)
- NanoEntek America, Inc. (U.S.)
- Nexcelom Bioscience LLC. (U.S.)
- PromoCell GmbH (Germany)
- RWD Life Science Co., LTD (China)
- Sartorius AG (Germany)
- Scientifica Instrumentation, Inc. (U.S.)
- SHIBUYA CORPORATION (Japan)
- Sphere Fluidics Limited (U.K.)
- Tecan Trading AG (Switzerland)
- Thrive Bioscience, Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of North America automated cell cultures market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: North America Automated Cell Cultures Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
